1. Home
  2. TFSL vs XENE Comparison

TFSL vs XENE Comparison

Compare TFSL & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • XENE
  • Stock Information
  • Founded
  • TFSL 1938
  • XENE 1996
  • Country
  • TFSL United States
  • XENE Canada
  • Employees
  • TFSL N/A
  • XENE N/A
  • Industry
  • TFSL Savings Institutions
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • XENE Health Care
  • Exchange
  • TFSL Nasdaq
  • XENE Nasdaq
  • Market Cap
  • TFSL 3.5B
  • XENE 3.0B
  • IPO Year
  • TFSL 2007
  • XENE 2014
  • Fundamental
  • Price
  • TFSL $14.38
  • XENE $42.23
  • Analyst Decision
  • TFSL Hold
  • XENE Strong Buy
  • Analyst Count
  • TFSL 2
  • XENE 10
  • Target Price
  • TFSL $14.00
  • XENE $57.30
  • AVG Volume (30 Days)
  • TFSL 301.3K
  • XENE 367.1K
  • Earning Date
  • TFSL 10-30-2024
  • XENE 11-12-2024
  • Dividend Yield
  • TFSL 7.85%
  • XENE N/A
  • EPS Growth
  • TFSL 7.69
  • XENE N/A
  • EPS
  • TFSL 0.28
  • XENE N/A
  • Revenue
  • TFSL $304,660,000.00
  • XENE N/A
  • Revenue This Year
  • TFSL N/A
  • XENE N/A
  • Revenue Next Year
  • TFSL $6.83
  • XENE $1,600.08
  • P/E Ratio
  • TFSL $51.00
  • XENE N/A
  • Revenue Growth
  • TFSL N/A
  • XENE N/A
  • 52 Week Low
  • TFSL $11.70
  • XENE $28.10
  • 52 Week High
  • TFSL $15.25
  • XENE $50.99
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 68.42
  • XENE 48.00
  • Support Level
  • TFSL $14.06
  • XENE $41.42
  • Resistance Level
  • TFSL $14.53
  • XENE $44.61
  • Average True Range (ATR)
  • TFSL 0.30
  • XENE 1.40
  • MACD
  • TFSL 0.14
  • XENE -0.15
  • Stochastic Oscillator
  • TFSL 91.80
  • XENE 25.94

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Share on Social Networks: